alzheimer-s

Documents about alzheimer-s

• A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.#214365PubMed
• A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease.#154199NCBI PubMed Central
• The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.#3727NCBI PubMed Central
• Single-Nuclei Transcriptomic Characterization of APOE4-Associated Alzheimer's Disease#151551bioRxiv / medRxiv
• Disease modifying treatments for Alzheimer's disease: Clinician perspectives.#159714NCBI PubMed Central
• Hyperglycosylation is a metabolic driver of Alzheimer's disease.#317680NCBI PubMed Central
• Generating Alzheimer's narratives using large language models.#360701NCBI PubMed Central
• Cross entropy gradient analysis for Alzheimer's disease assessment.#362112NCBI PubMed Central
• Effects of Hypoperfusion in Alzheimer's Disease#384150CiNii
• New perspectives on VEGF signalling in Alzheimer's disease.#422805NCBI PubMed Central
• AD-GPT: large language models in Alzheimer's disease.#433925NCBI PubMed Central
• APOE-ε4 genotype and western diet synergistically aggravate synaptic dysfunction in Alzheimer’s disease via d-serine disruption#7844HAL (France)
• Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer’s disease#205386Figshare
• Circulating sphingomyelins correlate with plasma T-tau in cognitively unimpaired older adults at risk of developing Alzheimer's disease#320845Research Online
• Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.#148152NCBI PubMed Central
• Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease#148864bioRxiv / medRxiv
• FuzzyFed-CNN: secure and explainable multimodal federated learning for early Alzheimer's diagnosis.#358310NCBI PubMed Central
• Grey- and white-matter resilience to tau, cognition and sex in Alzheimer's disease#379854bioRxiv / medRxiv
• Predicting 24-Month MCI-to-Alzheimer's Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic Testing#394545bioRxiv / medRxiv
• Enhancing brain delivery of tegaserod for Alzheimer’s disease: a pharmaceutical comparison of two nanocarrier-based strategies#388152HAL (France)
• Efeitos do programa AD-HOMEX nas funções cognitivas, no controle postural e desempenho funcional de idosos com doença de Alzheimer: um ensaio clínico randomizado e controlado#313285RI UFSCar
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths.#123059NCBI PubMed Central
• Cohort profile Davos Alzheimer's Collaborative DAC Egypt Cohort#125804Europe PMC
• The forgotten population: Early-onset Alzheimer's in people with Down syndrome.#140485NCBI PubMed Central
• A brain-penetrant P2X7R antagonist mitigates Alzheimer's disease pathology#162286bioRxiv / medRxiv
• Minor neuropsychological deficits and stage 2 of Alzheimer's disease.#185795NCBI PubMed Central
• Path integration in Alzheimer’s disease: orientation, movement and theta rhythmicity#196163PMC Full-Text (OAI)
• Continuum of Core 1 biomarkers in preclinical Alzheimer's disease.#242159NCBI PubMed Central
• Advances in the treatment of Alzheimer's disease.#334841NCBI PubMed Central
• Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease#360073HAL (France)
• Data-Driven Stochastic Model for Detecting Patientswith Alzheimer's Disease#363407bioRxiv / medRxiv
• Hunting for an Antigen: Humoral Immunity in Alzheimer's Disease.#367984NCBI PubMed Central
• Human Microglial Molecular Alterations in Aging and Alzheimer's Disease.#367989NCBI PubMed Central
• APOE4 Drives Uniquely Dysfunctional Human Microglial States in Alzheimer's Disease#379836bioRxiv / medRxiv
• Mapping Alzheimer's disease heterogeneity through exploratory unsupervised learning.#418313NCBI PubMed Central
• MALDI mass spectrometry imaging (MSI) reveals molecular and structural heterogeneity of amyloid-β in sporadic Alzheimer's disease and Down syndrome#5545Europe PMC
• Defying syntactic preservation in Alzheimer's disease: What type of impairment predicts syntactic change in dementia (if it does) and why?#377723Gestión del Repositorio Documental de la Universidad de Salamanca
• Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases.#9017NCBI PubMed Central
• Cohort profile Davos Alzheimer’s Collaborative DAC Egypt Cohort#123246Europe PMC
• History of hypertensive disorders of pregnancy and risk of Alzheimer's disease and vascular dementia.#170527NCBI PubMed Central
• An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.#174463NCBI PubMed Central
• Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer's Disease: a Systematic Review of Mechanistic Insights.#182307NCBI PubMed Central
• Blood - brain barrier breakdown and neurovascular unit failure in the progression of Alzheimer's disease.#193520NCBI PubMed Central
• Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors#353409ClinicalTrials.gov
• Gait Analysis Using Wearable Sensors in Patients With Alzheimer's Dementia: A Preliminary Report.#436977NCBI PubMed Central
• HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease#205302e-cienciaDatos Dataverse OAI Archive
• Gut microbiome composition, metabolic activity, and dietary associations in preclinical Alzheimer’s disease#336317Research Online
• Spatial proteomics of Alzheimer's disease-specific human microglial states.#9213NCBI PubMed Central
• Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures.#13429NCBI PubMed Central
• Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.#14806NCBI PubMed Central